Fordham 27 Recap: Reports 1-14 By Annsley Merelle Ward on Tuesday, May 07, 2019 #IPKat AmeriKat event report fordham 2019 +
Fordham 27 (Report 14): Priority By Annsley Merelle Ward on Thursday, May 02, 2019 #IPKat AmeriKat calculation of priority event report fordham 2019 invalid priority partial priority patent priority priority based on US provisionals priority rights +
Fordham 27 (Report 13): PTAB By Annsley Merelle Ward on Thursday, May 02, 2019 #IPKat AmeriKat event report fordham 2019 inter partes review PTAB PTAB appeal stay +
Fordham 27 (Report 12): SPCs By Annsley Merelle Ward on Tuesday, April 30, 2019 AmeriKat CJEU event report fordham 2019 manufacturing waiver marketing authorisation pharma R&D regulatory approval SPC SPC manufacturing waiver SPC regulation +
Fordham 27 (Report 11): Views from judicial decision makers By Annsley Merelle Ward on Tuesday, April 30, 2019 #IPKat AmeriKat event report fordham 2019 IP judges +
Fordham 27 (Report 10): Patent Potpurri By Annsley Merelle Ward on Tuesday, April 30, 2019 #IPKat AmeriKat doctrine of equivalents event report exhaustion fordham 2019 jurisdiction long arm patent patent eligibility patent infringement patentability +
Fordham 27 (Report 9): Biologics and Biosimilars By Annsley Merelle Ward on Sunday, April 28, 2019 #IPKat AmeriKat amgen v sanofi biologic launch biologics biosimilars BPCIA event report fordham 2019 humira injunctions launch psk9 +
Fordham 27 (Report 8): Second Medical Use/Plausibility By Annsley Merelle Ward on Sunday, April 28, 2019 #IPKat AmeriKat event report fordham 2019 implausibly industrial applicability plausibility second medical indication Second medical use Warner-Lambert +
Fordham 27 (Report 7): AI By Annsley Merelle Ward on Friday, April 26, 2019 #IPKat AI AmeriKat Artificial Intelligence copyright and AI event report fordham 2019 machine learning patent and AI +